The role of the T cell in autoimmune inflammation
暂无分享,去创建一个
P. Lipsky | A. Skapenko | H. Schulze-Koops | Peter E Lipsky | J. Leipe | Alla Skapenko | Jan Leipe | Hendrik Schulze-Koops
[1] M. Tykocinski,et al. Differential Regulation of Th1/Th2 Cytokine Responses by Placental Protein 141 , 2004, The Journal of Immunology.
[2] U. Wagner,et al. CD8 T Cells Are Required for the Formation of Ectopic Germinal Centers in Rheumatoid Synovitis , 2002, The Journal of experimental medicine.
[3] M. Waldor,et al. Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker. , 1985, Science.
[4] M. Dougados,et al. Treatment of Rheumatoid Arthritis by Selective Inhibition of T-Cell Activation with Fusion Protein CTLA 4 Ig , 2003 .
[5] F. Powrie,et al. Cutting Edge: Cure of Colitis by CD4+CD25+ Regulatory T Cells1 , 2003, The Journal of Immunology.
[6] T. Mak,et al. Immunologic Self-Tolerance Maintained by Cd25+Cd4+Regulatory T Cells Constitutively Expressing Cytotoxic T Lymphocyte–Associated Antigen 4 , 2000, The Journal of experimental medicine.
[7] J. Bluestone,et al. The B7 and CD28 receptor families. , 1994, Immunology today.
[8] Ehrenstein,et al. Compromised function of regulatory T cells in rheumatoid arthritis: Reversal by anti-TNF alpha therapy , 2004 .
[9] M. Feldmann,et al. Suppression of collagen-induced arthritis by continuous administration of IL-4. , 1997, Journal of immunology.
[10] F. Breedveld,et al. Collagen arthritis in the rat is initiated by CD4+ T cells and can be amplified by iron. , 1989, Cellular immunology.
[11] B. Haynes,et al. Increase in TCR gamma delta T lymphocytes in synovia from rheumatoid arthritis patients with active synovitis. , 1992, Journal of Clinical Immunology.
[12] P. Gregersen,et al. Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients. , 1996, Journal of immunology.
[13] P. Lipsky,et al. Altered memory T cell differentiation in patients with early rheumatoid arthritis. , 1999, Journal of immunology.
[14] G. Crabtree,et al. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. , 1991, Science.
[15] Hervé Groux,et al. A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.
[16] P. Tugwell,et al. The use of cyclosporin A in rheumatoid arthritis: conclusions of an international review. , 1994, British journal of rheumatology.
[17] B. Haynes,et al. Increase in TCRγδ T lymphocytes in synovia from rheumatoid arthritis patients with active synovitis , 1992, Journal of Clinical Immunology.
[18] A. Enk,et al. Identification and Functional Characterization of Human Cd4+Cd25+ T Cells with Regulatory Properties Isolated from Peripheral Blood , 2001, The Journal of experimental medicine.
[19] Arthur Weiss,et al. ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain , 1992, Cell.
[20] J. Farrés,et al. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon γ is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies , 2000, Annals of the rheumatic diseases.
[21] M. Byrne,et al. CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.
[22] M. Herrmann,et al. Restriction of De Novo Pyrimidine Biosynthesis Inhibits Th1 Cell Activation and Promotes Th2 Cell Differentiation1 , 2002, The Journal of Immunology.
[23] V. Taneja,et al. CD4 and CD8 T Cells in Susceptibility/Protection to Collagen-Induced Arthritis in HLA-DQ8-Transgenic Mice: Implications for Rheumatoid Arthritis1 , 2002, The Journal of Immunology.
[24] N. Macdonald,et al. Lymphocyte involvement in rheumatoid arthritis. Studies during thoracic duct drainage. , 1977, Arthritis and rheumatism.
[25] L. Davis,et al. Rheumatoid synovial CD4+ T cells exhibit a reduced capacity to differentiate into IL-4-producing T-helper-2 effector cells , 2000, Arthritis research.
[26] G. Panayi. Targeting of cells involved in the pathogenesis of rheumatoid arthritis. , 1999, Rheumatology.
[27] Choe,et al. Sulfasalazine prevents T‐helper 1 immune response by suppressing interleukin‐12 production in macrophages , 1999, Immunology.
[28] L. Cosmi,et al. Phenotype, Localization, and Mechanism of Suppression of CD4+CD25+ Human Thymocytes , 2002, The Journal of experimental medicine.
[29] U. Wagner,et al. The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis. , 1998, Journal of immunology.
[30] R. Winchester. The molecular basis of susceptibility to rheumatoid arthritis. , 1994, Advances in immunology.
[31] M. Lebwohl,et al. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. , 1999, The Journal of clinical investigation.
[32] J. Saurat,et al. A common precursor for CD4+ T cells producing IL-2 or IL-4. , 1992, Journal of immunology.
[33] H. Weiner. Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. , 2001, Microbes and infection.
[34] P. Ferrara,et al. Attenuation of collagen‐induced arthritis in mice by treatment with vector cells engineered to secrete interleukin‐13 , 1996, European journal of immunology.
[35] C. Thompson,et al. Regulation of surface and intracellular expression of CTLA4 on mouse T cells. , 1996, Journal of immunology.
[36] M. Dougados,et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. , 2003, The New England journal of medicine.
[37] P. Lipsky,et al. Anti-CD4 monoclonal antibody therapy in human autoimmune diseases. , 2000, Current directions in autoimmunity.
[38] C. June,et al. Cutting Edge: Regulatory T Cells from Lung Cancer Patients Directly Inhibit Autologous T Cell Proliferation1 , 2002, The Journal of Immunology.
[39] H. Schumacher,et al. Distinct patterns of cytokine secretion characterize new onset synovitis versus chronic rheumatoid arthritis. , 1998, The Journal of rheumatology.
[40] J. Bijlsma,et al. Mutual antagonism of rheumatoid arthritis and hay fever; a role for type 1/type 2 T cell balance , 1998, Annals of the rheumatic diseases.
[41] M. Salmon,et al. Human anergic/suppressive CD4+CD25+ T cells: a highly differentiated and apoptosis‐prone population , 2001, European journal of immunology.
[42] G. Freeman,et al. CD4+CD25high Regulatory Cells in Human Peripheral Blood1 , 2001, The Journal of Immunology.
[43] Abo,et al. Increase of CD57+ T cells in knee joints and adjacent bone marrow of rheumatoid arthritis (RA) patients: implication for an anti‐inflammatory role , 1998, Clinical and experimental immunology.
[44] A. McMichael,et al. Epitope specificity of clonally expanded populations of CD8+ T cells found within the joints of patients with inflammatory arthritis. , 2001, Arthritis and rheumatism.
[45] M. Rieder,et al. An alternate mechanism of glucocorticoid anti‐proliferative effect: promotion of a Th2 cytokine‐secreting profile , 1999, Clinical transplantation.
[46] M. Mack,et al. Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease , 2003, Nature Medicine.
[47] Ethan M. Shevach,et al. Cutting Edge: Depletion of CD4+CD25+ Regulatory T Cells Is Necessary, But Not Sufficient, for Induction of Organ-Specific Autoimmune Disease , 2002, The Journal of Immunology.
[48] S. Sriram,et al. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4 , 1985, The Journal of experimental medicine.
[49] D. Isenberg,et al. Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy , 2004, The Journal of experimental medicine.
[50] F. Breedveld,et al. T Cells Cloned from Human Rheumatoid Synovial Membrane Functionally Represent the Th 1 Subset , 1992, Scandinavian Journal of Immunology.
[51] R. Williamson,et al. Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide. , 1998, The Biochemical journal.
[52] M. Harigai,et al. IL‐4 down‐regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM‐rheumatoid factor production in patients with rheumatoid arthritis , 1992, Clinical and experimental immunology.
[53] R. Holmdahl,et al. Influence of CD4 or CD8 deficiency on collagen‐induced arthritis , 2001, Immunology.
[54] G. Schuler,et al. Ex Vivo Isolation and Characterization of Cd4+Cd25+ T Cells with Regulatory Properties from Human Blood , 2001, The Journal of experimental medicine.
[55] G. Krueger,et al. Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes. , 2001, The New England journal of medicine.
[56] D. Mason,et al. Human CD4+CD25+ thymocytes and peripheral T cells have immune suppressive activity in vitro , 2001, European journal of immunology.
[57] P. Krammer,et al. Involvement of Jun and Rel Proteins in Up-regulation of Interleukin-4 Gene Activity by the T Cell Accessory Molecule CD28* , 1998, The Journal of Biological Chemistry.
[58] D. Isenberg,et al. Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy. , 2000, Arthritis and rheumatism.
[59] P. Miossec,et al. Rheumatoid Inflammatory T‐Cell Clones express mostly Th1 but also Th2 and Mixed (Th0‐Like) Cytokine Patterns , 1993, Scandinavian journal of immunology.
[60] G. Müller,et al. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. , 2000, The Journal of rheumatology.
[61] K. De Groot,et al. Wegener's granulomatosis: disease course, assessment of activity and extent and treatment , 1998, Lupus.
[62] A. Calin,et al. Efficacy of total lymphoid irradiation in intractable rheumatoid arthritis. A double-blind, randomized trial , 1985 .
[63] H. Paulus,et al. Lymphocyte Involvement in Rheumatoid Arthritis , 1977 .
[64] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[65] R. V. van Lier,et al. Quantitation of interferon gamma- and interleukin-4-producing T cells in synovial fluid and peripheral blood of arthritis patients. , 1999, Rheumatology.
[66] A. Poole,et al. The induction of arthritis in mice by the cartilage proteoglycan aggrecan: roles of CD4+ and CD8+ T cells. , 1992, Cellular immunology.
[67] J. Banchereau,et al. Inhibition of the production of proinflammatory cytokines and immunoglobulins by interleukin-4 in an ex vivo model of rheumatoid synovitis. , 1992, Arthritis and rheumatism.
[68] F. Birg,et al. Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. , 1992, Journal of immunology.
[69] Kenneth M. Murphy,et al. Functional diversity of helper T lymphocytes , 1996, Nature.
[70] T. Spector,et al. The role of pregnancy in the course and aetiology of rheumatoid arthritis , 1992, Clinical Rheumatology.
[71] S. Hori,et al. Control of autoimmunity by naturally arising regulatory CD4+ T cells. , 2003, Advances in immunology.
[72] Ethan M. Shevach,et al. CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.
[73] L. Zhang,et al. Ligation of CD28 in vivo induces CD40 ligand expression and promotes B cell survival. , 1999, Journal of immunology.
[74] E. Shevach,et al. Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. , 2004, Seminars in immunology.
[75] D. Yocum,et al. T cells: pathogenic cells and therapeutic targets in rheumatoid arthritis. , 1999, Seminars in arthritis and rheumatism.
[76] L. Davis,et al. Elevated Th1- or Th0-like cytokine mRNA in peripheral circulation of patients with rheumatoid arthritis. Modulation by treatment with anti-ICAM-1 correlates with clinical benefit. , 1995, Journal of immunology.
[77] R. Germain. T-cell development and the CD4–CD8 lineage decision , 2002, Nature Reviews Immunology.
[78] M. Roncarolo,et al. Human Cd25+Cd4+ T Regulatory Cells Suppress Naive and Memory T Cell Proliferation and Can Be Expanded in Vitro without Loss of Function , 2001, The Journal of experimental medicine.
[79] P. Lehner,et al. CD8high+ (CD57+) T cells in patients with rheumatoid arthritis. , 1997, Arthritis and rheumatism.
[80] L. Joosten,et al. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis , 1999, Arthritis research.
[81] L. Davis,et al. Reduction of Th1 cell activity in the peripheral circulation of patients with rheumatoid arthritis after treatment with a non-depleting humanized monoclonal antibody to CD4. , 1998, The Journal of rheumatology.
[82] M. Lebwohl,et al. CTLA 4 Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris , 1999 .
[83] C. Thompson,et al. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. , 1995, Immunity.
[84] E. Lightfoot,et al. Role of CD11/CD18 in adhesion and transendothelial migration of T cells. Analysis utilizing CD18-deficient T cell clones. , 1991, Journal of immunology.
[85] C. Baecher-Allan,et al. Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis , 2003, European journal of immunology.
[86] J. Bijlsma,et al. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. , 2004, Arthritis and rheumatism.
[87] A. Weiss. T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein-tyrosine kinases , 1993, Cell.
[88] Stanley B. Cohen,et al. Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion. , 2002, Arthritis and rheumatism.
[89] A. Calin,et al. Destructive arthritis, rheumatoid factor, and HLA-DR4. Susceptibility versus severity, a case-control study. , 1989, Arthritis and rheumatism.
[90] L. Klareskog,et al. CD25brightCD4+ regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease , 2004, Arthritis research & therapy.
[91] J. Banchereau,et al. Interleukin-4 inhibits bone resorption through an effect on osteoclasts and proinflammatory cytokines in an ex vivo model of bone resorption in rheumatoid arthritis. , 1994, Arthritis and rheumatism.
[92] C W Turck,et al. ZAP-70: a 70 kd protein-tyrosine kinase that associates with the TCR zeta chain. , 1992, Cell.
[93] L. Davis,et al. Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1. , 1994, Arthritis and rheumatism.
[94] Hergen Spits,et al. Development of alphabeta T cells in the human thymus. , 2002, Nature reviews. Immunology.
[95] R. Coffman,et al. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. , 1986, Journal of immunology.
[96] S. Serjeantson,et al. Evidence for oligoclonality of T cell receptor δ chain transcripts expressed in rheumatoid arthritis patients , 1992, European journal of immunology.
[97] B. Mazières,et al. Antiinflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse transcriptase-polymerase chain reaction. , 1998, Arthritis and rheumatism.
[98] C. Hsieh,et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.
[99] S. Paget,et al. Predominantly T-cell infiltrate in rheumatoid synovial membranes. , 1975, The New England journal of medicine.
[100] K. Oizumi,et al. Analysis of type 1 and type 2 T cells in synovial fluid and peripheral blood of patients with rheumatoid arthritis. , 1998, The Journal of rheumatology.
[101] C. Thompson,et al. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.
[102] W. Seaman,et al. Reversal of advanced murine lupus in NZB/NZW F1 mice by treatment with monoclonal antibody to L3T4. , 1987, Journal of immunology.
[103] J. Bluestone,et al. The B 7 and CD 28 receptor families , 2022 .